NCT01191385 - GIDEON Non-Nexavar Arm - HCC Patients Who Are Treated With Any Therapy Other Than Nexavar at Individual Study Start | Biotech Hunter

Timeline

Start Date

November 30, 2010

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

Carcinoma, Hepatocellular

Interventions

DRUG

Any treatment for unresectable HCC as chosen by the physician

Only those patient are allowed to be enrolled that receive any HCC treatment for unresectable HCC as chosen by the physician except sorafenib. During the course of the study, each treatment is allowed.

Trial Locations (24)

Unknown

Multiple Locations